Alberta Investment Management Corp Makes New $5.02 Million Investment in Corteva, Inc. $CTVA

Alberta Investment Management Corp acquired a new stake in Corteva, Inc. (NYSE:CTVA) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 74,200 shares of the company’s stock, valued at approximately $5,018,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in CTVA. Chilton Capital Management LLC increased its holdings in Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after buying an additional 68,380 shares during the period. TriaGen Wealth Management LLC bought a new position in Corteva in the third quarter valued at approximately $4,284,000. Truist Financial Corp raised its position in Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after purchasing an additional 13,910 shares in the last quarter. New York State Teachers Retirement System boosted its holdings in shares of Corteva by 4.5% in the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after purchasing an additional 23,548 shares in the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of Corteva by 27.4% in the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock valued at $5,103,000 after purchasing an additional 16,261 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Up 0.5%

NYSE CTVA opened at $77.00 on Friday. The stock has a market capitalization of $51.78 billion, a P/E ratio of 48.74, a P/E/G ratio of 2.61 and a beta of 0.75. The business has a 50 day simple moving average of $70.51 and a 200 day simple moving average of $68.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $53.40 and a one year high of $77.41.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 45.57%.

Analysts Set New Price Targets

Several brokerages recently weighed in on CTVA. BNP Paribas Exane upped their price objective on Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a research report on Monday, November 17th. Bank of America increased their target price on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Rothschild & Co Redburn dropped their price objective on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Finally, JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and raised their target price for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.30.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.